messaggio

clik on the image and visit the new site

New site clik on the image

"In silico"


From Wikipedia
If the target host* of a phage therapy treatment is not an animal the term "biocontrol" (as in phage-mediated biocontrol of bacteria) is usually employed, rather than "phage therapy".

In silico
From:"Genomics,Proteomics and Clinical Bacteriology",N.Woodford and Alan P.Johnson

Phrase that emphasizes the fact that many molecular biologists spend increasing amounts of their time in front of a computer screen, generating hypotheses that can subsequently be tested and (hopefully) confirmed in the laboratory.


Phage Therapy is influenced by:

Phage therapy is influenced by:

Country : the epidemiological situation is different from country to country in terms of circulating bacteria and bacteriophages. Example: lytic phages from Italy may be no active on the same bacteria (genus and species) isolated from another country and vice versa.
Temporariness
Mutation rate
Phenotypical delay
Phage cocktail

My point of view

Saturday 8 May 2010

How to study the structure of lysin B from Mycobacteriophage D29

Go to old post


From
PDB Protein Data Bank:


Crystal structure of lysin B from Mycobacteriophage D29

1) download files:FASTA Sequence, PDB File (Text)

2)examine the protein by mEmboss software





3) if there are the transmembrane regions use MPEX software and Geneious





4)Download the protein file PDB in a Protein viewer software and observe

This is NBCI model.


These protein models are mine: